Photopheresis or extracorporeal photochemotherapy (ECP) is a novel immunomodulatory
therapy which involves separation of the patient's leucocyte‐rich plasma, followed by ex vivo …

Background: Extracorporeal photopheresis is a pheresis-based therapy that permits the
direct targeting of psoralen-mediated photochemotherapy to circulating pathogenic T cells …

Background Extracorporeal photopheresis (ECP) is an effective treatment for both acute and
chronic graft‐versus‐host disease (GVHD) in children and adults. Despite the large use of …

Extracorporeal photopheresis (ECP) is one of the most used and established therapies for
steroid‐refractory graft‐vs‐host disease (GvHD), with a good effect to side effect profile. In …

Extracorporeal photochemotherapy (ECP), or photopheresis, is a widely used treatment for
cutaneous T cell lymphoma (CTCL) and other T cell‐mediated disorders, having been …

Abstract Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory
therapy developed for cutaneous T‐cell lymphoma, has shown promise in treating chronic …

Extracorporeal phototherapy (ECP) is a therapeutic approach based on the biological effect
of psoralen 8-methoxypsoralen (8-MOP) and ultraviolet light A (UVA) on mononuclear cells …

Extracorporeal photopheresis (ECP) is used in the treatment of T‐cell‐mediated disorders.
However, the mechanism by which ECP achieves its effect remains illusive. Over recent …

Cutaneous T‐cell lymphoma (CTCL) is an indolent lymphoma usually of CD4+ T
lymphocytes in which the aggressive treatment for the advanced stages does not increase …

Background Cutaneous T-cell lymphoma (CTCL) includes several lymphoproliferative
disorders involving mature T-lymphocyte proliferation initially confined to the cutis. These …